Evidence supporting the use of: Piracetam
For the health condition: Strokes

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Piracetam has been studied for its potential role in supporting recovery after stroke, primarily due to its classification as a nootropic and its proposed neuroprotective and neurorestorative mechanisms. The rationale for its use is based on its ability to modulate neurotransmission, enhance neuronal plasticity, and improve microcirculation in the brain. Several randomized controlled trials and systematic reviews have investigated Piracetam in acute and chronic stroke patients. Some studies suggest modest improvements in certain cognitive and functional outcomes, particularly in language recovery after ischemic stroke (aphasia). For example, a Cochrane review (2012) analyzed available trials and found some positive effects, but the quality of evidence was low, and the clinical significance was uncertain.

Despite these findings, the overall evidence base is weak. Many trials had methodological limitations, small sample sizes, or inconsistent outcome measures. Major clinical guidelines do not recommend Piracetam as standard therapy for stroke due to insufficient high-quality evidence. Furthermore, regulatory agencies such as the US FDA and EMA have not approved Piracetam for stroke treatment. Its use persists in some countries, but primarily where regulatory standards differ. In summary, while there is some scientific investigation into Piracetam for stroke, the evidence supporting its effectiveness is limited and not robust enough for routine clinical use.

More about Piracetam
More about Strokes

Products containing Piracetam

We currently have no products on Vitabase that contain this ingredient.